Development of lacosamide for the treatment of partial-onset seizures

Lacosamide is an antiepileptic drug (AED) available in multiple formulations that was first approved in 2008 as adjunctive therapy for partial-onset seizures (POS) in adults. Unlike traditional sodium channel blockers affecting fast inactivation, lacosamide selectively enhances sodium channel slow i...

Descripción completa

Detalles Bibliográficos
Autores principales: Doty, Pamela, Hebert, David, Mathy, Francois-Xavier, Byrnes, William, Zackheim, James, Simontacchi, Kelly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759704/
https://www.ncbi.nlm.nih.gov/pubmed/23859801
http://dx.doi.org/10.1111/nyas.12213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759704/
https://www.ncbi.nlm.nih.gov/pubmed/23859801
http://dx.doi.org/10.1111/nyas.12213

Ejemplares similares